Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival
- 8 February 2013
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 42 (5) , 1271-1282
Abstract
Antisynthetase syndrome is characterised by the association of interstitial lung disease and myositis with different anti-tRNA-synthetase antibodies. The occurrence, aetiology and prognosis of pulmonary hypertension have not yet been evaluated.Among 203 consecutive patients, transthoracic echocardiogram and right heart catheterisation results were retrospectively analysed in the light of clinico-biological, morphological and functional parameters. Definitions of pulmonary hypertension were based on the European Society of Cardiology/European Respiratory Society 2009 guidelines, with severe pulmonary hypertension being defined by a mean pulmonary arterial pressure >35 mmHg.Pulmonary hypertension was suspected by transthoracic echocardiogram in 47 (23.2%) cases, corresponding to pulmonary hypertension “possible” (n=27, 13.3%) or “likely” (n=20, 9.9%). Right heart catheterisation was performed in 21 patients, excluding pulmonary hypertension in five and confirming pre-capillary pulmonary hypertension in 16 (7.9%). Although related to interstitial lung disease in all cases, pre-capillary pulmonary hypertension was severe in 13 (81.3%) patients (mean±sdpulmonary arterial pressure 46±9 mmHg), frequently associated with low cardiac index (mean±sd2.3±0.8 L·min−1·m−2) and high forced vital capacity/diffusing capacity of the lung for carbon monoxide ratio (2.5±0.6). Pulmonary hypertension was significantly associated with a lower survival rate (p<0.001), with a 3-year survival rate of 58%.The occurrence of pulmonary hypertension in antisynthetase syndrome is significant and dramatically worsens the prognosis. Although systematically associated with interstitial lung disease, pulmonary hypertension was usually severe, suggesting a specific pulmonary vascular involvement.Keywords
This publication has 32 references indexed in Scilit:
- Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificityAutoimmunity Reviews, 2012
- Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertensionLupus, 2011
- Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodiesInternal Medicine Journal, 2011
- Clinical cardiac involvement in idiopathic inflammatory myopathies: A systematic reviewInternational Journal of Cardiology, 2011
- Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies: Table 1–European Respiratory Journal, 2011
- Severe pulmonary hypertension in Anti–Jo‐1 syndromeArthritis Care & Research, 2010
- Pulmonary hypertension in polymyositis-dermatomyositis: clinical and hemodynamic characteristics and response to vasoactive therapyLupus, 2009
- Sera from anti–Jo‐1–positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cellsArthritis & Rheumatism, 2009
- Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie studyRheumatology, 2008
- Unusually high frequency of autoantibodies to PL‐7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositisArthritis & Rheumatism, 2006